STRUCTURE THERAPEUTICS INC. - AMERICAN DEPOSITARY

Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update

29 سبتمبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights

10 أغسطس 2023 16:05:01 بحسب Nasdaq GlobeNewswire

Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors

03 أغسطس 2023 17:32:00 بحسب Nasdaq GlobeNewswire

Structure Therapeutics to Present at Jefferies Healthcare Conference

31 مايو 2023 16:30:00 بحسب Nasdaq GlobeNewswire

Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity

25 مايو 2023 16:30:00 بحسب Nasdaq GlobeNewswire

Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International Conference

18 مايو 2023 16:30:00 بحسب Nasdaq GlobeNewswire

Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights

11 مايو 2023 16:30:00 بحسب Nasdaq GlobeNewswire

Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights

30 مارس 2023 16:30:00 بحسب Nasdaq GlobeNewswire